Global Cancer Biomarkers Market Outlook 2021

1 Cancer Biomarkers Market Overview

• 1.1 Product Overview and Scope of Cancer Biomarkers
• 1.2 Cancer Biomarkers Segment by Type
  • 1.2.1 Global Cancer Biomarkers Sales Growth Rate Comparison by Type (2020-2026)
  • 1.2.2 Protein Biomarkers
  • 1.2.3 Genetic Biomarkers
  • 1.2.4 Others
• 1.3 Cancer Biomarkers Segment by Application
  • 1.3.1 Cancer Biomarkers Sales Comparison by Application: (2020-2026)
  • 1.3.2 Breast Cancer
  • 1.3.3 Lung Cancer
  • 1.3.4 Colorectal Cancer
  • 1.3.5 Melanoma
  • 1.3.6 Blood Cancer
  • 1.3.7 Prostate Cancer
  • 1.3.8 Ovarian Cancer
  • 1.3.9 Stomach Cancer
  • 1.3.10 Liver Cancer
• 1.4 Global Cancer Biomarkers Market Size Estimates and Forecasts
  • 1.4.1 Global Cancer Biomarkers Revenue 2015-2026
  • 1.4.2 Global Cancer Biomarkers Sales 2015-2026
  • 1.4.3 Cancer Biomarkers Market Size by Region: 2020 Versus 2026

2 Global Cancer Biomarkers Market Competition by Manufacturers

• 2.1 Global Cancer Biomarkers Sales Market Share by Manufacturers (2015-2020)
• 2.2 Global Cancer Biomarkers Revenue Share by Manufacturers (2015-2020)
• 2.3 Global Cancer Biomarkers Average Price by Manufacturers (2015-2020)
• 2.4 Manufacturers Cancer Biomarkers Manufacturing Sites, Area Served, Product Type
• 2.5 Cancer Biomarkers Market Competitive Situation and Trends
  • 2.5.1 Cancer Biomarkers Market Concentration Rate
  • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
  • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
• 2.7 Primary Interviews with Key Cancer Biomarkers Players (Opinion Leaders)

3 Cancer Biomarkers Retrospective Market Scenario by Region

• 3.1 Global Cancer Biomarkers Retrospective Market Scenario in Sales by Region: 2015-2020
• 3.2 Global Cancer Biomarkers Retrospective Market Scenario in Revenue by Region: 2015-2020
• 3.3 North America Cancer Biomarkers Market Facts & Figures by Country
  • 3.3.1 North America Cancer Biomarkers Sales by Country
  • 3.3.2 North America Cancer Biomarkers Sales by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Cancer Biomarkers Market Facts & Figures by Country
  • 3.4.1 Europe Cancer Biomarkers Sales by Country
  • 3.4.2 Europe Cancer Biomarkers Sales by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Cancer Biomarkers Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Cancer Biomarkers Sales by Region
  • 3.5.2 Asia Pacific Cancer Biomarkers Sales by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Cancer Biomarkers Market Facts & Figures by Country
  • 3.6.1 Latin America Cancer Biomarkers Sales by Country
  • 3.6.2 Latin America Cancer Biomarkers Sales by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Cancer Biomarkers Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Cancer Biomarkers Sales by Country
  • 3.7.2 Middle East and Africa Cancer Biomarkers Sales by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 U.A.E

4 Global Cancer Biomarkers Historic Market Analysis by Type

• 4.1 Global Cancer Biomarkers Sales Market Share by Type (2015-2020)
• 4.2 Global Cancer Biomarkers Revenue Market Share by Type (2015-2020)
• 4.3 Global Cancer Biomarkers Price Market Share by Type (2015-2020)
• 4.4 Global Cancer Biomarkers Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Cancer Biomarkers Historic Market Analysis by Application

• 5.1 Global Cancer Biomarkers Sales Market Share by Application (2015-2020)
• 5.2 Global Cancer Biomarkers Revenue Market Share by Application (2015-2020)
• 5.3 Global Cancer Biomarkers Price by Application (2015-2020)

6 Company Profiles and Key Figures in Cancer Biomarkers Business

• 6.1 Abbott Laboratories
  • 6.1.1 Corporation Information
  • 6.1.2 Abbott Laboratories Description, Business Overview
  • 6.1.3 Abbott Laboratories Cancer Biomarkers Sales, Revenue and Gross Margin (2015-2020)
  • 6.1.4 Abbott Laboratories Products Offered
  • 6.1.5 Abbott Laboratories Recent Development
• 6.2 Thermo Fisher Scientific
  • 6.2.1 Thermo Fisher Scientific Corporation Information
  • 6.2.2 Thermo Fisher Scientific Description, Business Overview
  • 6.2.3 Thermo Fisher Scientific Cancer Biomarkers Sales, Revenue and Gross Margin (2015-2020)
  • 6.2.4 Thermo Fisher Scientific Products Offered
  • 6.2.5 Thermo Fisher Scientific Recent Development
• 6.3 F. Hoffmann-La Roche Ltd
  • 6.3.1 F. Hoffmann-La Roche Ltd Corporation Information
  • 6.3.2 F. Hoffmann-La Roche Ltd Description, Business Overview
  • 6.3.3 F. Hoffmann-La Roche Ltd Cancer Biomarkers Sales, Revenue and Gross Margin (2015-2020)
  • 6.3.4 F. Hoffmann-La Roche Ltd Products Offered
  • 6.3.5 F. Hoffmann-La Roche Ltd Recent Development
• 6.4 Illumina,Inc.
  • 6.4.1 Illumina,Inc. Corporation Information
  • 6.4.2 Illumina,Inc. Description, Business Overview
  • 6.4.3 Illumina,Inc. Cancer Biomarkers Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 Illumina,Inc. Products Offered
  • 6.4.5 Illumina,Inc. Recent Development
• 6.5 Agilent Technologies
  • 6.5.1 Agilent Technologies Corporation Information
  • 6.5.2 Agilent Technologies Description, Business Overview
  • 6.5.3 Agilent Technologies Cancer Biomarkers Sales, Revenue and Gross Margin (2015-2020)
  • 6.5.4 Agilent Technologies Products Offered
  • 6.5.5 Agilent Technologies Recent Development
• 6.6 Qiagen NV
  • 6.6.1 Qiagen NV Corporation Information
  • 6.6.2 Qiagen NV Description, Business Overview
  • 6.6.3 Qiagen NV Cancer Biomarkers Sales, Revenue and Gross Margin (2015-2020)
  • 6.6.4 Qiagen NV Products Offered
  • 6.6.5 Qiagen NV Recent Development
• 6.7 Merck & Co.
  • 6.6.1 Merck & Co. Corporation Information
  • 6.6.2 Merck & Co. Description, Business Overview
  • 6.6.3 Merck & Co. Cancer Biomarkers Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 Merck & Co. Products Offered
  • 6.7.5 Merck & Co. Recent Development
• 6.8 Hologic,Inc.
  • 6.8.1 Hologic,Inc. Corporation Information
  • 6.8.2 Hologic,Inc. Description, Business Overview
  • 6.8.3 Hologic,Inc. Cancer Biomarkers Sales, Revenue and Gross Margin (2015-2020)
  • 6.8.4 Hologic,Inc. Products Offered
  • 6.8.5 Hologic,Inc. Recent Development
• 6.9 Novartis AG
  • 6.9.1 Novartis AG Corporation Information
  • 6.9.2 Novartis AG Description, Business Overview
  • 6.9.3 Novartis AG Cancer Biomarkers Sales, Revenue and Gross Margin (2015-2020)
  • 6.9.4 Novartis AG Products Offered
  • 6.9.5 Novartis AG Recent Development
• 6.10 BioMerieux SA
  • 6.10.1 BioMerieux SA Corporation Information
  • 6.10.2 BioMerieux SA Description, Business Overview
  • 6.10.3 BioMerieux SA Cancer Biomarkers Sales, Revenue and Gross Margin (2015-2020)
  • 6.10.4 BioMerieux SA Products Offered
  • 6.10.5 BioMerieux SA Recent Development
• 6.11 Genomic Health
  • 6.11.1 Genomic Health Corporation Information
  • 6.11.2 Genomic Health Cancer Biomarkers Description, Business Overview
  • 6.11.3 Genomic Health Cancer Biomarkers Sales, Revenue and Gross Margin (2015-2020)
  • 6.11.4 Genomic Health Products Offered
  • 6.11.5 Genomic Health Recent Development
• 6.12 Affymetrix
  • 6.12.1 Affymetrix Corporation Information
  • 6.12.2 Affymetrix Cancer Biomarkers Description, Business Overview
  • 6.12.3 Affymetrix Cancer Biomarkers Sales, Revenue and Gross Margin (2015-2020)
  • 6.12.4 Affymetrix Products Offered
  • 6.12.5 Affymetrix Recent Development
• 6.13 Roche Diagnostics Ltd.
  • 6.13.1 Roche Diagnostics Ltd. Corporation Information
  • 6.13.2 Roche Diagnostics Ltd. Cancer Biomarkers Description, Business Overview
  • 6.13.3 Roche Diagnostics Ltd. Cancer Biomarkers Sales, Revenue and Gross Margin (2015-2020)
  • 6.13.4 Roche Diagnostics Ltd. Products Offered
  • 6.13.5 Roche Diagnostics Ltd. Recent Development

7 Cancer Biomarkers Manufacturing Cost Analysis

• 7.1 Cancer Biomarkers Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Raw Materials Price Trend
  • 7.1.3 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Cancer Biomarkers
• 7.4 Cancer Biomarkers Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Cancer Biomarkers Distributors List
• 8.3 Cancer Biomarkers Customers

9 Market Dynamics

• 9.1 Market Trends
• 9.2 Opportunities and Drivers
• 9.3 Challenges
• 9.4 Porter's Five Forces Analysis

10 Global Market Forecast

• 10.1 Global Cancer Biomarkers Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Cancer Biomarkers by Type (2021-2026)
  • 10.1.2 Global Forecasted Revenue of Cancer Biomarkers by Type (2021-2026)
• 10.2 Cancer Biomarkers Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Cancer Biomarkers by Application (2021-2026)
  • 10.2.2 Global Forecasted Revenue of Cancer Biomarkers by Application (2021-2026)
• 10.3 Cancer Biomarkers Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Cancer Biomarkers by Region (2021-2026)
  • 10.3.2 Global Forecasted Revenue of Cancer Biomarkers by Region (2021-2026)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List